Purging of peripheral blood progenitor cell autografts and treatment of minimal residual disease

Stem Cells

Volumn 15, Issue SUPPL. 1, 1997, Pages 159-165

  Brugger, Wolfram ^a   Scheding, Stefan ^a   Bock, Thomas ^a   Ziegler, Benedikt ^a   Kanz, Lothar ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Dendritic cells; Ex vivo expansion; Minimal residual disease; Peripheral blood progenitor cell transplantation; Purging; Selection of CD34+ cells

Indexed keywords

AUTOGRAFT; CONFERENCE PAPER; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MARKER GENE; MINIMAL RESIDUAL DISEASE; STEM CELL TRANSPLANTATION; TUMOR CELL;

ANTIGENS, CD34; CELL SEPARATION; CLINICAL TRIALS; DENDRITIC CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; NEOPLASM, RESIDUAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; TRANSPLANTATION, AUTOLOGOUS;

EID: 0030726737     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.5530150820     Document Type: Article

References (38)

1. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993;341:85-86.
2. Rill DR, Santana VM, Roberts WM et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 1994;84:380-383.
3. + cells present in autologous transplants of chronic myelogeneous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994;83:3068-3076.
4. Gribben JG, Freedman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B cell lymphoma. N Engl J Med 1991;325:1525-1533.
5. Berardi AC, Wang A, Levine JD et al. Functional isolation and characterization of human hematopoietic stem cells. Science 1995;267:104-108.
6. Lee YY, Kim ES, Seol JG et al. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia. Blood 1996;88:2201-2209.
7. Lee YY, Kim ES, Seol JG et al. Effect of a vitamin D3 analog, EB1089, on hematopoietic stem cells from normal and myeloid leukemic blasts. Leukemia 1996;10:1751-1757.
8. Bühring HJ, Dill P, Kanz L et al. Differential expression of receptor tyrosine kinases c-kit, c-fms, FLT-3, PDGF-RA/RB, HER2, HER3, and the mucin molecule MUC-1 on primary acute leukemic blasts. Blood 1996;88:366a.
9. Ross AA, Cooper BW, Lazarus HM et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993;82:2605-2610.
10. Shpall EJ, Jones RB. Release of tumor cells from bone marrow. Blood 1994;83:623-625.
11. Brugger W, Bross KJ, Glatt M et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994;83:636-640.
12. Sharp JG, Joshi SS, Armitage JO et al. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by culture techniques. Blood 1992;79:1074-1080.
13. + cells to remove circulating tumor cells. Blood 1996;87:1625-1634.
14. +peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995;86:390-397.
15. + bone marrow progentior cells in patients with non-Hodskin's lymphoma. Blood 1995;85:1647-1654.
16. Berenson RJ, Shpall EJ, Franklin WA et al. Transplantation of CD34 positive marrow and/or peripheral blood progenitor cells into breast cancer patients following high-dose chemotherapy. Bone Marrow Transplant 1995;15(suppl 2):S32.
17. Dreger P, von Neuhoff N, Suttorp M et al. Rapid engraftment of peripheral blood progenitor cell grafts purged with B cell-specific monoclonal antibodies and immunomagnetic beads. Bone Marrow Transplant 1995;16:627-629.
18. + selection systems or CAMPATH-1. Exp Hematol 1995;23:147-154.
19. +progenitor cells by stem cell factor, interleukin-1β, interleukin-6, interleukin-3, interferon-gamma, and erythropoietin. Blood 1993;81:2579-2584.
20. +cells into the myeloid lineage. Blood 1992;80:1405-1412.
21. + cells from patients with stage IV breast cancer. Blood 1994;84:3567-3574.
22. Emerson SG. Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. Blood 1996;87:3082-3088.
23. +-selected human peripheral blood progenitor cells. Blood 1994;84:2898-2903.
24. Kessinger A. Circulating stem cells - waxing hematopoietic. N Engl J Med 1995;333:315-316.
25. Brugger W, Heimfeld S, Berenson RJ et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 1995;333:283-287.
26. Petzer AL, Hogge DE, Landsdorp PM et al. Self-renewal of primitive human hematopoietic cells (long-term culture initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 1996;93:1470-1474.
27. Peters SO, Kittler ELW, Ramshaw HS et al. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996;87:30-37.
28. Yonemura Y, Ku H, Hirayama F et al. Interleukin-3 or interleukin-1 abrogates the reconstitution ability of hematopoietic stem cells. Proc Natl Acad Sci USA 1996;93:4040-4044.
29. Spangrude GJ, Brooks DM, Tumas DB. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood 1995;85:1006-1016.
30. Munch MO, Firpo MT, Moore MAS. Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without loss of stem cell lineage and proliferative potential. Blood 1993;81:3463-3473.
31. Zijlmans JM, Visser JW, Kleiverda K et al. Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulatins ability. Proc Natl Acad Sci USA 1995;92:8901-8905.
32. + peripheral blood progenitor cells: implications for the expansion of contaminating tumor cells. Blood 1996;88:2707-2713.
33. Brugger W, Scheding S, Vogel W et al. Purging of peripheral blood progenitor cells. Ann Oncol 1996;7(suppl):11-132.
34. + hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC-positive Langerhans cell and the interdigitating dendritic cell type. Blood 1996;88:2541-2548.
35. + hematopoietic progenitor cells in cancer patients. Eur J Immunol 1996;26:595-600.
36. Peters HJ, Gieseler R, Thiele B et al. Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today 1996;17:273-278.
37. Maraskovsky E, Brasel K, Teepe M et al. Dramatic increase in the numbers of functionally mature dendritic cells in FLT3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med 1996;184:1953-1962.
38. + peripheral blood progenitor cells. Blood 1996;88:299a.